Literature DB >> 15322419

Association of norepinephrine transporter gene with methylphenidate response.

Li Yang1, Yu-Feng Wang, Jun Li, Stephen V Faraone.   

Abstract

OBJECTIVE: This study aimed to explore the association between alleles of the norepinephrine transporter gene and the methylphenidate response.
METHOD: Chinese Han youths with attention-deficit/hyperactivity disorder recruited in the Outpatient Department of the Institute of Mental Health from 2001 to 2004 were treated with methylphenidate in doses of 0.45 to 0.60 mg/kg per day. Behavior changes were measured by the ADHD Rating Scale-IV when optimal doses were reached. The single-nucleotide polymorphic allele of norepinephrine transporter gene G1287A was used as the genetic marker, and the genotypes were identified by restriction fragment length polymorphism analysis.
RESULTS: A significant association was found between norepinephrine transporter gene G1287A genotypes and response to methylphenidate for hyperactive-impulsive subscale scores (mean score reduction was 7.15 and 6.94 for G/G and G/A genotype, respectively, and 2.13 for A/A; p = .012) but not inattentive scores.
CONCLUSIONS: These findings suggest an association between the G1287A polymorphism of the norepinephrine transporter gene and variation in methylphenidate response. Further work is needed to confirm this finding and to assess its generalization to other ethnic groups. Copyright 2004 American Academy of Child and Adolescent Psychiatry

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322419     DOI: 10.1097/01.chi.0000131134.63368.46

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  27 in total

1.  Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Authors:  Francesco Napolitano; Alessandra Bonito-Oliva; Mauro Federici; Manolo Carta; Francesco Errico; Salvatore Magara; Giuseppina Martella; Robert Nisticò; Diego Centonze; Antonio Pisani; Howard H Gu; Nicola B Mercuri; Alessandro Usiello
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

Review 2.  Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder.

Authors:  James C Ermer; Ben A Adeyi; Michael L Pucci
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

3.  A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD.

Authors:  Ziarih Hawi; Natasha Matthews; Edwina Barry; Aiveen Kirley; Joseph Wagner; Robyn H Wallace; Helen S Heussler; Alasdair Vance; Michael Gill; Mark A Bellgrove
Journal:  Psychopharmacology (Berl)       Date:  2012-09-29       Impact factor: 4.530

Review 4.  Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Authors:  Marianne O Klein; Daniella S Battagello; Ariel R Cardoso; David N Hauser; Jackson C Bittencourt; Ricardo G Correa
Journal:  Cell Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.046

Review 5.  Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Authors:  Tanya E Froehlich; James J McGough; Mark A Stein
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

6.  Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.

Authors:  Boong-Nyun Kim; Jae-Won Kim; Soon Beom Hong; Soo-Churl Cho; Min-Sup Shin; Hee-Jeong Yoo
Journal:  Behav Brain Funct       Date:  2010-10-07       Impact factor: 3.759

Review 7.  The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.

Authors:  Mark A Stein; James J McGough
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

8.  Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.

Authors:  Maureen K Hahn; Angela Steele; R Steven Couch; Mark A Stein; Jessica J Krueger
Journal:  Neuropharmacology       Date:  2009-08-19       Impact factor: 5.250

9.  A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.

Authors:  James J McGough; James T McCracken; Sandra K Loo; Marc Manganiello; Michael C Leung; Jeremy R Tietjens; Thao Trinh; Shilpa Baweja; Robert Suddath; Susan L Smalley; Gerhard Hellemann; Catherine A Sugar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-12       Impact factor: 8.829

10.  Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children.

Authors:  Li Yang; Qiujin Qian; Lu Liu; Haimei Li; Stephen V Faraone; Yufeng Wang
Journal:  J Neural Transm (Vienna)       Date:  2012-12-25       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.